Dr. Anthony Fauci said Wednesday that a drug manufacturer’s recent decision to pause clinical trials of a potential coronavirus vaccine because a test subject got sick is unfortunate, but not uncommon in the pharmaceutical industry, Reuters reported.
Across the world, multiple pharmaceutical manufacturers are working to get a vaccine against SARS-CoV-2, the pathogen colloquially referred to as the “novel coronavirus,” developed and deployed as soon as possible. Ordinarily, producing a vaccine takes years, but researchers are working quickly in order to put the brakes on the COVID-19 pandemic as quickly as possible.
Unfortunately, one such manufacturer, AstraZeneca, suffered a setback this week. The manufacturer is currently carrying out large-scale clinical trials of the so-called “Oxford vaccine,” a serum developed in cooperation with a team of researchers at the British university that appears to have a good chance at being safe and effective. However, the pharmaceutical giant announced that it is pausing its own trials after a patient came down with an unexplained illness.
0 comments :
Post a Comment